Federal Circuit Affirms Judge’s Acceptance Of Patent Reissuance For Medication
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on March 13 held that a biopharmaceutical patent holder was entitled to a patent term extension (PTE) for a reissued...To view the full article, register now.
Already a subscriber? Click here to view full article